Mynd Life Sciences
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – M
MYND Diagnostics was formed to commercialize proprietary biomarker diagnostic tests for patients suffering from MDD, TRD and other...
Mynd Life Sciences
- Sep 29, 2021
MYND Life Sciences Inc. Announces RSU Grant
VANCOUVER, BC, Sept. 29, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND” or the “Company“), has granted an aggregate of 234,192 restricted...
Mynd Life Sciences
- Sep 9, 2021
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offer
VANCOUVER, BC, Sept. 9, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND” or the “Company“) is pleased to announce,...